Filing Details

Accession Number:
0001209191-17-039190
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-06-12 16:46:42
Reporting Period:
2017-06-12
Filing Date:
2017-06-12
Accepted Time:
2017-06-12 16:46:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
827871 Eagle Pharmaceuticals Inc. EGRX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1590862 A. Pete Meyers C/O Eagle Pharmaceuticals, Inc.
50 Tice Blvd., Suite 315
Woodcliff Lake NJ 07677
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-06-12 350 $71.49 350 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $71.4414 to $71.55, inclusive. TheReporting Person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request,full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.